Refractory or Recurrent Solid Tumors, Excluding CNS Tumors
1 clinical trials · Condition
◉ Watch Refractory or Recurrent Solid Tumors, Excluding CNS Tumors
| Record | Firm | Date |
|---|---|---|
| VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors (NCT02164838) | Children's Oncology Group | 2014-09-01 |
Track Refractory or Recurrent Solid Tumors, Excluding CNS Tumors automatically
Every clearance here is in the API, with alerts when new ones post.